TerminatedNCT01467713

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolarity type I

Medication studyAges 18–75Multiple countries

The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Listed locations: Birmingham and 155 more locationsSee all locations and recruitment
Study phase: Phase 3

Get this study by email

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 2011

Recruitment status: Terminated
Enrollment listed in the registry: 642
Sponsor: Takeda
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United States, Argentina, Chile, ...
Age range: From 18 Years to 75 Years
Official registry ID: NCT01467713
Official title: Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar I Disorder in Adult Patients

Recruitment & locations

Terminated

Birmingham, United States · Dothan, United States · Muscle Shoals, United States

151 more locations

Phoenix, United States
Little Rock, United States
Bellflower, United States
Costa Mesa, United States
Garden Grove, United States
Harbor City, United States
Huntington Park, United States
Irvine, United States
Lomita, United States
Long Beach, United States
Los Angeles, United States
Murrieta, United States
National City, United States
Oceanside, United States
Orange, United States
Paramount, United States
Rancho Cucamonga, United States
Redondo Beach, United States
Riverside, United States
Sacramento, United States
San Diego, United States
San Jose, United States
San Ramon, United States
Sherman Oaks, United States
Torrance, United States
Wildomar, United States
Colorado Springs, United States
Denver, United States
Norwalk, United States
Washington D.C., United States
Clearwater, United States
Coral Gables, United States
Coral Springs, United States
Edgewater, United States
Hialeah, United States
Jacksonville, United States
Leesburg, United States
Miami, United States
Miami Beach, United States
Miami Lakes, United States
Orange City, United States
Orlando, United States
Pembroke Pines, United States
Plantation, United States
Port Charlotte, United States
Saint Cloud, United States
Tampa, United States
Vero Beach, United States
Atlanta, United States
Dunwoody, United States
East Point, United States
Smyrna, United States
Suwanee, United States
Honolulu, United States
Chicago, United States
Gurnee, United States
Libertyville, United States
Skokie, United States
Brownsburg, United States
Manhattan, United States
Topeka, United States
Wichita, United States
Elizabethtown, United States
Lexington, United States
Paducah, United States
Mandeville, United States
Metairie, United States
Baltimore, United States
Boston, United States
Fall River, United States
Bloomfield Hills, United States
Detroit, United States
Kalamazoo, United States
Flowood, United States
Hazelwood, United States
Saint Charles, United States
St Louis, United States
Washington, United States
Lincoln, United States
Las Vegas, United States
Cherry Hill, United States
Albuquerque, United States
Brooklyn, United States
Cedarhurst, United States
Fresh Meadows, United States
New York, United States
Rochester, United States
Staten Island, United States
Charlotte, United States
Columbiana, United States
Durham, United States
Greensboro, United States
Raleigh, United States
Salisbury, United States
Wilmington, United States
Fargo, United States
Cincinnati, United States
Cleveland, United States
Dayton, United States
Franklin, United States
Oklahoma City, United States
Portland, United States
Allentown, United States
Duncansville, United States
Harleysville, United States
McMurray, United States
Media, United States
Philadelphia, United States
Pittsburgh, United States
Columbia, United States
Greer, United States
Old Point Station, United States
Clarksville, United States
Knoxville, United States
Memphis, United States
Austin, United States
Bellaire, United States
Corpus Christi, United States
Dallas, United States
Irving, United States
Nassau Bay, United States
Plano, United States
San Antonio, United States
Bountiful, United States
Newport News, United States
Norfolk, United States
Richmond, United States
Virginia Beach, United States
Kirkland, United States
Richland, United States
Seattle, United States
Clarksburg, United States
Milwaukee, United States
Buenos Aires, Argentina
Córdoba, Argentina
Mendoza, Argentina
Santa Fe, Argentina
Antofagasta, Chile
Arauco, Chile
Elqui, Chile
Santiago, Chile
Bello, Colombia
Antioquia, Colombia
Barranquilla, Colombia
Bogotá, Colombia
Mexicali, Mexico
León, Mexico
Mexico City, Mexico
Monterrey, Mexico
Mérida, Mexico
México, Mexico

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Takeda.

Does this study involve medication?

Yes. The study involves medication, including Ramelteon SL and Placebo.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies